Grace Therapeutics, Inc. Income Tax Credits and Adjustments
Grace Therapeutics, Inc. (GRCE) reported Income Tax Credits and Adjustments of $0 for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxCreditsAndAdjustments · last filed 2025-06-23
- Grace Therapeutics, Inc. income tax credits and adjustments for fiscal 2025 was $0.00.
- Grace Therapeutics, Inc. income tax credits and adjustments for fiscal 2024 was -$55.00K.
| Period end | Income Tax Credits and Adjustments 12 month |
|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-06-23 |
| 2024-03-31 | -$55.00K 10-K · filed 2025-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |